financetom
Business
financetom
/
Business
/
BRIEF-Titan Provides Update On Planned Merger With Conavi
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Titan Provides Update On Planned Merger With Conavi
May 17, 2024 2:20 PM

May 17 (Reuters) - Titan Medical Inc ( TMDIF ):

* TITAN PROVIDES UPDATE ON PLANNED MERGER WITH CONAVI

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Integrated Electrical Services Fiscal Q3 Adjusted Earnings, Revenue Climb; Board Approves $200 Million Buyback
Integrated Electrical Services Fiscal Q3 Adjusted Earnings, Revenue Climb; Board Approves $200 Million Buyback
Aug 2, 2024
08:42 AM EDT, 08/02/2024 (MT Newswires) -- Integrated Electrical Services (IESC) reported fiscal Q3 adjusted earnings Friday of $2.67 per diluted share, up from $1.08 a year earlier. Revenue for the quarter ended June 30 was $768.4 million, up from $584.4 million a year earlier. Analysts' estimates were not readily available for comparison. The company also said its board has...
Sector Update: Consumer
Sector Update: Consumer
Aug 2, 2024
08:48 AM EDT, 08/02/2024 (MT Newswires) -- Consumer stocks were mixed premarket Friday as the Consumer Staples Select Sector SPDR Fund (XLP) was up 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) fell by 3.6% recently. Church & Dwight ( CHD ) shares fell by more than 4% after the consumer goods company said it expects Q3 adjusted...
Atmus Filtration Q2 Adjusted Earnings, Sales Rise; 2024 Outlook Updated -- Shares Gain Pre-Bell
Atmus Filtration Q2 Adjusted Earnings, Sales Rise; 2024 Outlook Updated -- Shares Gain Pre-Bell
Aug 2, 2024
08:51 AM EDT, 08/02/2024 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q2 adjusted earnings Friday of $0.71 per diluted share, up from $0.63 a year earlier. Analysts polled by Capital IQ expected $0.58. Net sales for the quarter ended June 30 were $432.6 million, up from $413.6 million a year earlier. Analysts surveyed by Capital IQ expected...
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
Aug 2, 2024
Thursday, the FDA approved Adaptimmune Therapeutics ( ADAP ) plc’s Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma, a rare type of cancer that tends to occur near large joints, mainly the knees. The approval covers patients who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and whose tumor expresses the MAGE-A4 antigen. This indication is approved under...
Copyright 2023-2026 - www.financetom.com All Rights Reserved